Cargando…

Opsoclonus as a suspected paraneoplastic syndrome of endometrial cancer

Paraneoplastic opsoclonus is well described in neuroblastoma. In the adult oncologic population, opsoclonus is seen usually within the context of opsoclonus–myoclonus ataxia and is associated most strongly with small-cell lung cancer. Patients with paraneoplastic opsoclonus are often seronegative. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Mark A, Hartmann, Lynn C, LaChance, Daniel H, Jimenez, Rafael E
Formato: Texto
Lenguaje:English
Publicado: PagePress 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994525/
https://www.ncbi.nlm.nih.gov/pubmed/21139958
http://dx.doi.org/10.4081/rt.2010.e42
_version_ 1782192959247089664
author Lewis, Mark A
Hartmann, Lynn C
LaChance, Daniel H
Jimenez, Rafael E
author_facet Lewis, Mark A
Hartmann, Lynn C
LaChance, Daniel H
Jimenez, Rafael E
author_sort Lewis, Mark A
collection PubMed
description Paraneoplastic opsoclonus is well described in neuroblastoma. In the adult oncologic population, opsoclonus is seen usually within the context of opsoclonus–myoclonus ataxia and is associated most strongly with small-cell lung cancer. Patients with paraneoplastic opsoclonus are often seronegative. Patients with gynecologic malignancies are known to be predisposed to paraneoplastic syndromes; however, we describe the first case of paraneoplastic opsoclonus in association with endometrial cancer.
format Text
id pubmed-2994525
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher PagePress
record_format MEDLINE/PubMed
spelling pubmed-29945252010-12-07 Opsoclonus as a suspected paraneoplastic syndrome of endometrial cancer Lewis, Mark A Hartmann, Lynn C LaChance, Daniel H Jimenez, Rafael E Rare Tumors Case Report Paraneoplastic opsoclonus is well described in neuroblastoma. In the adult oncologic population, opsoclonus is seen usually within the context of opsoclonus–myoclonus ataxia and is associated most strongly with small-cell lung cancer. Patients with paraneoplastic opsoclonus are often seronegative. Patients with gynecologic malignancies are known to be predisposed to paraneoplastic syndromes; however, we describe the first case of paraneoplastic opsoclonus in association with endometrial cancer. PagePress 2010-09-30 /pmc/articles/PMC2994525/ /pubmed/21139958 http://dx.doi.org/10.4081/rt.2010.e42 Text en ©Copyright M.A. Lewis et al., 2010 This work is licensed under a Creative Commons Attribution 3.0 License (by-nc 3.0). Licensee PAGEPress, Italy
spellingShingle Case Report
Lewis, Mark A
Hartmann, Lynn C
LaChance, Daniel H
Jimenez, Rafael E
Opsoclonus as a suspected paraneoplastic syndrome of endometrial cancer
title Opsoclonus as a suspected paraneoplastic syndrome of endometrial cancer
title_full Opsoclonus as a suspected paraneoplastic syndrome of endometrial cancer
title_fullStr Opsoclonus as a suspected paraneoplastic syndrome of endometrial cancer
title_full_unstemmed Opsoclonus as a suspected paraneoplastic syndrome of endometrial cancer
title_short Opsoclonus as a suspected paraneoplastic syndrome of endometrial cancer
title_sort opsoclonus as a suspected paraneoplastic syndrome of endometrial cancer
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994525/
https://www.ncbi.nlm.nih.gov/pubmed/21139958
http://dx.doi.org/10.4081/rt.2010.e42
work_keys_str_mv AT lewismarka opsoclonusasasuspectedparaneoplasticsyndromeofendometrialcancer
AT hartmannlynnc opsoclonusasasuspectedparaneoplasticsyndromeofendometrialcancer
AT lachancedanielh opsoclonusasasuspectedparaneoplasticsyndromeofendometrialcancer
AT jimenezrafaele opsoclonusasasuspectedparaneoplasticsyndromeofendometrialcancer